DeepMed Research

UNIVERSITY OF MIAMI

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: https://continue.miami.edu/packagedetail.aspx

Clinical Trials

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Phase 4

Recruiting

Conditions: Crohn Disease

Interventions: Drug: Tirzepatide
Behavioral: Mediterranean diet

First Posted Date: 2025-01-14

Last Posted Date: 2025-05-01

Lead Sponsor: University of Miami

Target Recruit Count: 24

Registration Number: NCT06774079

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
University of Miami, Miami, Florida, United States

FITLIGHT Reliability and Acute Training Effects

Not Applicable

Recruiting

Conditions: Athletic Injuries

First Posted Date: 2024-12-27

Last Posted Date: 2025-04-22

Lead Sponsor: University of Miami

Target Recruit Count: 30

Registration Number: NCT06748417

Locations: 🇺🇸
University of Miami, Coral Gables, Florida, United States

The Use of Cyproheptadine in Pediatric Feeding Disorders

Phase 4

Recruiting

Conditions: Pediatric Feeding Disorder, Chronic
Avoidant Restrictive Food Intake Disorder

Interventions: Behavioral: Nutritional Counseling
Drug: Cyproheptadine
Behavioral: Behavioral Counseling

First Posted Date: 2024-12-27

Last Posted Date: 2025-01-16

Lead Sponsor: University of Miami

Target Recruit Count: 50

Registration Number: NCT06751290

Locations: 🇺🇸
University of Miami Department of Pediatric Gastroenterology, Miami, Florida, United States

General vs Spinal in Total Joint Arthroplasty (TJA)

Not Applicable

Recruiting

Conditions: Knee Osteoarthritis
Hip Osteoarthritis

First Posted Date: 2024-12-24

Last Posted Date: 2025-02-21

Lead Sponsor: University of Miami

Target Recruit Count: 2396

Registration Number: NCT06747494

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Advancing Equitable Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Not Applicable

Not yet recruiting

Conditions: HIV Infections

First Posted Date: 2024-12-12

Last Posted Date: 2025-05-08

Lead Sponsor: University of Miami

Target Recruit Count: 32

Registration Number: NCT06730555

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma

Phase 1

Recruiting

Conditions: CNS Lymphoma

Interventions: Drug: Zanubrutinib
Drug: Methotrexate
Drug: Polatuzumab Vedotin
Drug: Rituximab
Drug: Cyclophosphamide
Drug: Doxorubicin
Drug: Prednisone

First Posted Date: 2024-12-12

Last Posted Date: 2025-05-08

Lead Sponsor: Juan P. Alderuccio, MD

Target Recruit Count: 20

Registration Number: NCT06730542

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Effect of Music and Mindfulness Meditation

Not Applicable

Completed

Conditions: Anxiety

First Posted Date: 2024-11-26

Last Posted Date: 2025-04-27

Lead Sponsor: University of Miami

Target Recruit Count: 9

Registration Number: NCT06704841

Locations: 🇺🇸
University of Miami, Coral Gables, Florida, United States

Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease

Not Applicable

Active, not recruiting

Conditions: Chronic Graft-Versus-Host Disease
Quality of Life

First Posted Date: 2024-11-14

Last Posted Date: 2025-05-07

Lead Sponsor: University of Miami

Target Recruit Count: 20

Registration Number: NCT06688942

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)

Not Applicable

Recruiting

Conditions: Spinal Cord Injuries
Peripheral Nerve Injuries

First Posted Date: 2024-11-04

Last Posted Date: 2024-11-22

Lead Sponsor: University of Miami

Target Recruit Count: 60

Registration Number: NCT06672458

Locations: 🇺🇸
University of Miami - Miami Project to Cure Paralysis, Miami, Florida, United States

Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

Phase 2

Recruiting

Conditions: Chronic Graft Versus Host Disease
cGVHD

Interventions: Biological: Axatilimab
Procedure: Extracorporeal Photopheresis

First Posted Date: 2024-10-29

Last Posted Date: 2025-05-20

Lead Sponsor: University of Miami

Target Recruit Count: 49

Registration Number: NCT06663722

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy